Literature DB >> 24768827

Beta-blockers in cirrhosis: therapeutic window or an aspirin for all?

Alberto Ferrarese1, Emmanuel Tsochatzis2, Andrew Kenneth Burroughs2, Marco Senzolo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24768827     DOI： 10.1016/j.jhep.2014.03.038

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

Review 1.  Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool.

Authors:  Q Wu; X Zhao; H You
Journal:  Braz J Med Biol Res       Date:  2017-05-18       Impact factor: 2.590

3.  Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites.

Authors:  Alberto Ferrarese; Valerie Tikhonoff; Edoardo Casiglia; Paolo Angeli; Silvano Fasolato; Diego Faggian; Alberto Zanetto; Giacomo Germani; Francesco Paolo Russo; Patrizia Burra; Marco Senzolo
Journal:  Gastroenterol Res Pract       Date:  2018-05-09       Impact factor: 2.260
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.